JAAOS - 2026-10-15 - Journal Article; Review
Low-dose Radiation Therapy for Benign Orthopaedic Conditions.
Mohiuddin MM, Ruffer JE, Siddiqi A, Makda J
Topics
Key Takeaway
Low-dose radiation therapy (0.5–1 Gy/fraction, total 3–6 Gy) produces meaningful pain relief and functional improvement in osteoarthritis and enthesopathies refractory to conventional treatment, with minimal acute or long-term toxicity.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This narrative review examines the evidence for low-dose radiation therapy (LDRT) in benign orthopaedic conditions including osteoarthritis and enthesopathies, synthesizing clinical outcomes, mechanistic data, and consensus society recommendations. Standard regimens of 0.5–1 Gy per fraction to a total of 3–6 Gy demonstrate pain relief and functional improvement in patients refractory to traditional therapies, with anti-inflammatory and immunomodulatory mechanisms proposed. Randomized trials and systematic reviews cited within the review reveal ongoing controversy regarding efficacy and optimal dosing, and major radiation societies endorse LDRT as a noninvasive adjunct with careful patient selection.
Key Limitation
The review does not perform a systematic search or meta-analysis, so the cited pain relief and functional improvement claims lack pooled effect sizes, confidence intervals, or heterogeneity assessment, making it impossible to quantify the magnitude of benefit.
Original Abstract
Low-dose radiation therapy is increasingly used for benign orthopaedic conditions, including osteoarthritis and enthesopathies, with typical regimens of 0.5 to 1 Gy per fraction and total doses of 3 to 6 Gy. Clinical studies demonstrate notable pain relief and functional improvement, particularly in patients refractory to traditional therapies, with minimal acute and long-term toxicity. Mechanistic insights reveal anti-inflammatory and immunomodulatory effects, supporting its use in degenerative and hyperproliferative musculoskeletal disorders. However, randomized trials and systematic reviews highlight ongoing controversies regarding efficacy and optimal dosing, emphasizing the need for additional high-quality trials. Consensus statements from major radiation societies recommend low-dose radiation therapy as a noninvasive adjunct for many patients, with careful patient selection and multidisciplinary collaboration.